{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:34Z","timestamp":1786995634941,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008438","name":"AHA","doi-asserted-by":"publisher","award":["TPA34170522"],"award-info":[{"award-number":["TPA34170522"]}],"id":[{"id":"10.13039\/100008438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL146818"],"award-info":[{"award-number":["R01HL146818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01AG073581"],"award-info":[{"award-number":["K01AG073581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL14877"],"award-info":[{"award-number":["R01HL14877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI153142"],"award-info":[{"award-number":["R01AI153142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.peptides.2024.171201","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T12:18:56Z","timestamp":1711714736000},"page":"171201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Dysfunction of the renin-angiotensin-aldosterone system in human septic shock"],"prefix":"10.1016","volume":"176","author":[{"given":"Christopher L.","family":"Schaich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Leisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal R.","family":"Filbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2024.171201_bib1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.peptides.2024.171201_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te","year":"2015","journal-title":"Circ. Res"},{"key":"10.1016\/j.peptides.2024.171201_bib3","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system \u2013 the good, bad and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2024.171201_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic Renin-Angiotensin Systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.peptides.2024.171201_bib5","first-page":"1","article-title":"of active renin content with mortality in critically ill patients: a\u00a0post-hoc analysis of the VICTAS trial","volume":"50","author":"Busse","year":"2023","journal-title":"Crit. Care Med"},{"key":"10.1016\/j.peptides.2024.171201_bib6","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients","volume":"23","author":"Lesnik","year":"2022","journal-title":"J. Mol. Sci."},{"key":"10.1016\/j.peptides.2024.171201_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit. Care Med"},{"key":"10.1016\/j.peptides.2024.171201_bib8","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin ii for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"2","key":"10.1016\/j.peptides.2024.171201_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit. Care Med"},{"key":"10.1016\/j.peptides.2024.171201_bib10","first-page":"699","article-title":"Angiotensinogen: more than its downstream products: evidence from population studies and novel therapeutics","volume":"10","author":"Kahlon","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2024.171201_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.peptides.2024.171201_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1681\/ASN.2014010085","article-title":"Multiple genes of the renin-angiotensin system are novel targets of Wnt\/\u03b2-catenin signaling","volume":"26","author":"Zhou","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib13","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1681\/ASN.2016070811","article-title":"(Pro)renin receptor is an amplifier of Wnt\/\u03b2-Catenin signaling in kidney injury and fibrosis.","volume":"28","author":"Li","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000525635","article-title":"Soluble (Pro)renin receptor in hypertension","volume":"147","author":"Yang","year":"2023","journal-title":"Nephron"},{"key":"10.1016\/j.peptides.2024.171201_bib15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1161\/CIRCRESAHA.123.321883","article-title":"Renin-angiotensin system and sex differences in COVID-19: A critical assessment","volume":"132","author":"Chappell","year":"2023","journal-title":"Circ. Res"},{"key":"10.1016\/j.peptides.2024.171201_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.peptides.2024.171201_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fendo.2013.00201","article-title":"Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways","volume":"4","author":"Chappell","year":"2014","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.peptides.2024.171201_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/pharmrev.120.000281","article-title":"The Angiotensin AT(2) Receptor: from a binding site to a novel therapeutic target","volume":"74","author":"Steckelings","year":"2022","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.peptides.2024.171201_bib19","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the Renin-Angiotensin System: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.peptides.2024.171201_bib20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2011121159","article-title":"Liver angiotensinogen is the primary source of renal Angiotensin II","volume":"23","author":"Matsusaka","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib21","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/ATVBAHA.121.316590","article-title":"Renal angiotensinogen is predominantly liver-derived in nonhuman primates","volume":"41","author":"Kukida","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.peptides.2024.171201_bib22","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00246.2016","article-title":"Angiotensinogen import in isolated proximal tubules: evidence for mitochondrial trafficking and uptake","volume":"312","author":"Wilson","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.peptides.2024.171201_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2004.04998.x","article-title":"Renin-angiotensin system expression in rat bone marrow hematopoietic and stromal cells","volume":"126","author":"Strawn","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.peptides.2024.171201_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1096\/fj.10-169433","article-title":"Angiotensin-converting enzyme is required for normal myelopoiesis","volume":"25","author":"Lin","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2024.171201_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4049\/jimmunol.161.1.430","article-title":"Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis","volume":"161","author":"Ruiz-Ortega","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2024.171201_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2016-11-752006","article-title":"Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils","volume":"130","author":"Khan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2024.171201_bib27","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M110.163782","article-title":"Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus","volume":"285","author":"Okwan-Duodu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2024.171201_bib28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00134-009-1545-x","article-title":"Antagonist of the type-1 ANG II receptor prevents against LPS-induced septic shock in rats","volume":"35","author":"Hagiwara","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.peptides.2024.171201_bib29","doi-asserted-by":"crossref","first-page":"R1092","DOI":"10.1152\/ajpregu.00700.2002","article-title":"Ang II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats","volume":"284","author":"Miyoshi","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.peptides.2024.171201_bib30","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.176.9.5577","article-title":"Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines","volume":"176","author":"Mateo","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.peptides.2024.171201_bib31","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1161\/01.CIR.0000148824.93600.F3","article-title":"Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines","volume":"110","author":"Nabah","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2024.171201_bib32","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the Angiotensin II Type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2024.171201_bib33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00210-014-1014-0","article-title":"What is the role of renin inhibition during rat septic conditions: preventive effect of aliskerin on sepsis-induced lung injury","volume":"387","author":"Akpinar","year":"2014","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.peptides.2024.171201_bib34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1681\/ASN.2015060683","article-title":"Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI","volume":"27","author":"Zhang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib35","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCRESAHA.111.261768","article-title":"A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ. Res"},{"key":"10.1016\/j.peptides.2024.171201_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/ALN.0000000000003365","article-title":"Mineralocorticoid dysfunction during critical illness: A Review of the Evidence","volume":"133","author":"Nethathe","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.peptides.2024.171201_bib37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4266\/kjccm.2017.00094","article-title":"Implication of plasma renin activity and plasma aldosterone concentration in critically ill patients with septic shock","volume":"32","author":"Chung","year":"2017","journal-title":"Korean J. Crit. Care Med."},{"key":"10.1016\/j.peptides.2024.171201_bib38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.1983.00350040125016","article-title":"Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient","volume":"143","author":"Davenport","year":"1983","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.peptides.2024.171201_bib39","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","article-title":"Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure","volume":"29","author":"du Cheyron","year":"2003","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.peptides.2024.171201_bib40","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1152\/ajpregu.00314.2018","article-title":"Separate and interacting effects of the endogenous circadian system and behaviors on plasma aldosterone in humans","volume":"316","author":"Thosar","year":"2019","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.peptides.2024.171201_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-023-04518-2","article-title":"Genomics of Pediatric Septic Shock Investigators. Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock","volume":"12","author":"Pode-Shakked","year":"2023","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.peptides.2024.171201_bib42","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.peptides.2024.171201_bib43","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/SHK.0000000000001285","article-title":"Plasma renin concentration is associated with hemodynamic deficiency and adverse renal outcome in septic shock","volume":"52","author":"Nguyen","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.peptides.2024.171201_bib44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-021-03725-z","article-title":"Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study","volume":"25","author":"Flannery","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12882-020-01974-8","article-title":"Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib46","doi-asserted-by":"crossref","first-page":"k4891","DOI":"10.1136\/bmj.k4891","article-title":"Sepsis associated acute kidney injury","volume":"364","author":"Poston","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.peptides.2024.171201_bib47","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s00467-023-05930-0","article-title":"Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock","volume":"38","author":"Stanski","year":"2023","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.peptides.2024.171201_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.153986","article-title":"RAS inhibition and sepsis-associated acute kidney injury","volume":"69","author":"Flannery","year":"2022","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib49","first-page":"709","article-title":"Association between premorbid renin-angiotensin-aldosterone system blockade and the risk of acute kidney injury in critically ill patients","volume":"39","author":"Chou","year":"2023","journal-title":"Acta Cardiol. Sin."},{"key":"10.1016\/j.peptides.2024.171201_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajem.2022.10.006","article-title":"Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis","volume":"62","author":"Hasegawa","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.peptides.2024.171201_bib51","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3390\/jcm12144566","article-title":"Role of the Renin Angiotensin Aldosterone System in the pathogenesis of sepsis-Induced acute kidney injury: A systematic review","volume":"12","author":"Tibi","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.peptides.2024.171201_bib52","article-title":"The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.peptides.2024.171201_bib53","doi-asserted-by":"crossref","unstructured":"J.A. Tumlin, R. Murugan, A.M. Deane, M. Ostermann, L.W. Busse, K.R. Ham, K. Kashani, H.M. Szerlip, J.R. Prowle, A. Bihorac, K.W. Finkel, A. Zarbock, L.G. Forni, S.J. Lynch, J. Jensen, S. Kroll, L.S. Chawla, G.F. Tidmarsh, R. Bellomo. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators (2018). Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II. Crit Care Med 46 (2018) 949\u2013957.","DOI":"10.1097\/CCM.0000000000003092"},{"key":"10.1016\/j.peptides.2024.171201_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13054-023-04396-8","article-title":"Angiotensin-(1-7) in an experimental septic shock model","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib55","article-title":"Angiotensin-(1-7) attenuates sepsis-induced acute kidney injury by regulating the NF-\u03baB pathway.","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.peptides.2024.171201_bib56","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/01.CIR.102.16.2011","article-title":"Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury","volume":"102","author":"Orfanos","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2024.171201_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.peptides.2024.171201_bib58","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.RA120.014183","article-title":"Dipeptidyl peptidase 3 modulates the renin\u2013angiotensin system in mice.","volume":"295","author":"Jha","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2024.171201_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLOS One"},{"key":"10.1016\/j.peptides.2024.171201_bib60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Srrnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.peptides.2024.171201_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4166\/kjg.2020.75.4.182","article-title":"Liver dysfunction in sepsis","volume":"25","author":"Kim","year":"2020","journal-title":"Korean J. Gastroenterol."},{"key":"10.1016\/j.peptides.2024.171201_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(91)90501-N","article-title":"Low angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurements","volume":"90","author":"Arnal","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.peptides.2024.171201_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20060444","article-title":"Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance","volume":"400","author":"Stanley","year":"2006","journal-title":"Biochem J."},{"key":"10.1016\/j.peptides.2024.171201_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/BJ20120801","article-title":"Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein","volume":"449","author":"Kl\u00f8verpris","year":"2013","journal-title":"Biochem J."},{"key":"10.1016\/j.peptides.2024.171201_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn3777","article-title":"Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity","volume":"8","author":"Briquez","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.peptides.2024.171201_bib66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin II type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171201_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury","volume":"99","author":"Leisman","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.peptides.2024.171201_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211370119","article-title":"Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model","volume":"119","author":"Leisman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.peptides.2024.171201_bib69","first-page":"252","article-title":"Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes","volume":"10","author":"Li","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.peptides.2024.171201_bib70","first-page":"E414","article-title":"Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy","volume":"265","author":"Hilgenfeldt","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.peptides.2024.171201_bib71","doi-asserted-by":"crossref","first-page":"25095","DOI":"10.1016\/S0021-9258(19)74575-X","article-title":"Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylyl cyclase activity and stabilizing angiotensinogen mRNA","volume":"268","author":"Klett","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2024.171201_bib72","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/ars.2015.6498","article-title":"Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 inflammasome via redox balance modulation","volume":"24","author":"Cai","year":"2016","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.peptides.2024.171201_bib73","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jcmgh.2021.05.017","article-title":"(Pro)renin receptor knockdown attenuates liver fibrosis through inactivation of ERK\/TGF-\u03b21\/SMAD3 pathway.","volume":"12","author":"Hsieh","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.peptides.2024.171201_bib74","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/jcm10040702","article-title":"Update on new aspects of the Renin-Angiotensin System in hepatic fibrosis and portal hypertension: implications for novel therapeutic options","volume":"10","author":"Rajapaksha","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.peptides.2024.171201_bib75","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"ATHOS-3 Investigators (2017) Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.peptides.2024.171201_bib76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"22","author":"Wieruszewski","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib77","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: the ARAMIS study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"10.1016\/j.peptides.2024.171201_bib78","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13054-023-04739-5","article-title":"The alternative renin angiotensin system in critically ill patients: pathophysiology and therapeutic implications","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13054-023-04396-8","article-title":"Angiotensin-(1-7) in an experimental septic shock model","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.peptides.2024.171201_bib80","article-title":"Angiotensin-(1-7) attenuates sepsis-induced acute kidney injury by regulating the NF-\u03baB pathway.","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.peptides.2024.171201_bib81","article-title":"Myeloid ACE2 protects against septic hypotension and vascular dysfunction through Ang-(1-7)-Mas-mediated macrophage polarization","volume":"18","author":"Li","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.peptides.2024.171201_bib82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/atm-22-6016","article-title":"Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin-(1-7)","volume":"11","author":"Wu","year":"2023","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.peptides.2024.171201_bib83","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.2023.3546","article-title":"Effect of renin-angiotensin system modulation with synthetic angiotensin (1-7) [TXA-127] and an AT1R biased ligand [TRV-027] among adults with COVID-19-induced acute lung injury: randomized clinical trials","volume":"29","author":"Self","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.peptides.2024.171201_bib84","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/1440-1681.12085","article-title":"Do intravenous and subcutaneous angiotensin II increase blood pressure by different mechanisms?","volume":"40","author":"Campbell","year":"2013","journal-title":"Clin. Exp. Pharm. Physiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:40:33Z","timestamp":1777527633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978124000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":84,"alternative-id":["S0196978124000548"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171201","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfunction of the renin-angiotensin-aldosterone system in human septic shock","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"171201"}}